JAK2 and lung carcinoma: It caused S-phase arrest, suppressed cell migration, and inhibited the JAK2/STAT3 (Janus kinase 2/signal transducer and activator of transcription 3) signaling pathway, suggesting its role as a lung cancer therapeutic agent [23].